Health Law Alliance regularly advises compliance officers weighing whether to self-disclose a suspected False Claims Act violation before the government finds it first. DOJ's cooperation credit framework, codified at Justice Manual Section 4-4.112 since May 2019, rewards early, complete disclosure with a real reduction in exposure. It does not erase liability, and the same disclosure that earns the company credit can expose the individuals who committed the conduct to separate civil or criminal risk. What DOJ rewards, what it expects in return, and what the framework does not protect against is the first decision point in any internal investigation.
What Earns Cooperation Credit Under DOJ Policy
DOJ evaluates cooperation credit in a False Claims Act matter against four factors: timeliness and voluntariness, the truthfulness and completeness of the information provided, the nature and extent of the assistance, and its significance to the government's recovery. Credit accrues along three tracks: voluntary self-disclosure, meaningful cooperation, and remediation. Maximum credit generally requires proactive self-disclosure, identifying every individual substantially involved in the conduct, full cooperation, and remedial steps addressing the root cause. Remediation, root-cause analysis, discipline of those involved, and a strengthened compliance program, also shapes whether the settlement comes bundled with a corporate integrity agreement. Partial credit remains available to a defendant that falls short of the maximum standard but still provides meaningful assistance, which is the more common outcome in practice.
The Disclosure DOJ Expects
A disclosure earns the strongest credit only when it is proactive and made before the government or a qui tam relator already knows about the conduct; disclosure that follows an unsealed complaint or an active audit can still help, but it competes for a smaller pool of credit. DOJ weighs specific conduct when scoring cooperation: identifying the individuals substantially involved, preserving and producing documents beyond what a subpoena already requires, making witnesses available for interviews, and assisting the government in quantifying and recovering the loss. Complying with a preexisting legal or contractual obligation to report does not, by itself, count as voluntary self-disclosure. A compliance program that surfaces a violation through a routine audit still has to make an affirmative decision to bring the facts to the government.
What Cooperation Credit Does Not Buy
Cooperation credit is a settlement-value question. It reduces the multiplier DOJ applies, but it does not resolve whether the claims were material to the government's payment decision, a separate defense covered in the materiality defense analysis following the Supreme Court's Escobar decision. Nor does it change the floor DOJ works from when calculating the treble damages and per-claim penalties a defendant otherwise faces.
Even with maximum cooperation credit, DOJ will not settle a False Claims Act matter for less than the government's full compensation: single damages, lost interest, investigation costs, and the relator's share.
The policy does not require a company to waive attorney-client privilege or work product protection to qualify for credit; DOJ's own guidance states that eligibility is not predicated on a privilege waiver. In practice, sharing the factual results of an internal investigation, witness accounts, timelines, and document indexes, functions close to a waiver even when the privilege itself stays formally intact.
The Tradeoffs Compliance Officers Should Weigh
Identifying culpable individuals is a precondition for any cooperation credit, a standard that traces to the Department's 2015 individual accountability policy. That requirement puts the company's interest in credit into direct tension with the interests of the executives and staff named in the disclosure. An employee identified in a self-disclosure can face separate civil exposure, a criminal referral, or an OIG exclusion action, regardless of how the company's settlement resolves. Self-disclosure to DOJ's Civil Division also does not bind the Criminal Division; facts turned over for civil cooperation credit can surface in a parallel criminal review, a distinction covered in keeping civil exposure and criminal charges apart. A compliance officer weighing disclosure is choosing between a known, bounded cost and the uncertain cost of the government finding the conduct independently and pursuing treble damages, per-claim penalties, and exclusion without any credit at all.
Why Early Legal Counsel Is Critical
It is critical that healthcare providers promptly retain experienced healthcare defense counsel before deciding whether, when, and how to disclose suspected False Claims Act conduct to the government. The self-disclosure decision is not reversible; once facts are in the government's hands, a company cannot withdraw them to protect its negotiating position or shield an individual employee. Counsel retained early can scope an internal investigation, evaluate whether disclosure is likely to be discovered independently, structure the disclosure to protect privilege where possible, and manage the separate interests of the company and its employees before those interests diverge in ways that are difficult to fix later.
How Health Law Alliance Can Help
Health Law Alliance advises pharmacies, physician practices, and healthcare companies on the disclosure decision, before a suspected billing pattern becomes a government inquiry, and after a subpoena or civil investigative demand has already arrived. If your organization is weighing whether to self-disclose, or has already received a government inquiry into billing conduct, contact us for a free, confidential consultation through our False Claims Act defense practice.
